News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jermasek Douglas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2023 |
4
| Jermasek Douglas (EVP of Corporate Strategy) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Exercised 104,612 shares
@ $0
Exercised 50 convertible preferred
@ $0.49, valued at
$24.5
Exercised 79,252 options to buy
@ $0.54, valued at
$42.8k
Exercised 72,047 warrants
@ $0.59, valued at
$42.5k
Exercised 115,275 warrants
@ $0.74, valued at
$85.3k
|
|
| 03/09/2023 |
4
| Jermasek Douglas (EVP of Corporate Strategy) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Granted 50 convertible preferred
@ $1000, valued at
$50k
|
|
| 11/23/2022 |
4
| Jermasek Douglas (EVP of Corporate Strategy) has filed a Form 4 on Unicycive Therapeutics, Inc.|
Txns:
| Granted 55,000 options
@ $0.75, valued at
$41.3k
|
|
| 11/21/2022 |
3
| Jermasek Douglas (EVP of Corporate Strategy) has filed a Form 3 on Unicycive Therapeutics, Inc. |
|
|